Sanjeev Dani Joins Aurobindo Pharma as COO

Aurobindo Pharma specializes in the research, development, manufacturing and marketing of active pharmaceutical ingredients and generic pharmaceuticals. The group's activity is organized around 2 product families : - generic drugs: for the treatment of neurological, cardiovascular, viral, gastroenterological, ophthalmologic and chronic diseases; - active pharmaceutical ingredients. At the end of March 2018, the group operated 23 production sites in India (19), the United States (3) and Brazil. Net sales are distributed geographically as follows: India (12%), the United States (46.5%), Europe (31.2%) and other (10.3%).